Grundinformationen
- Standard-SMILES
CCCCC[C@H](O)/C=C/[C@H]1C=CC(=O)[C@@H]1CCCCCCC(=O)O- InChIKey
BGKHCLZFGPIKKU-LDDQNKHRSA-N- Summenformel
- C20H32O4
- Durchschnittliche Molmasse
- 336,5 g/mol
- Monoisotopische Masse
- 336,2300595
Überblick
Prostaglandin A1 is a prostaglandins A. It is a conjugate acid of a prostaglandin A1(1-).
Namen und Bezeichner
- Bevorzugter Name
- Pga1
- IUPAC
- 7-[(1R,2S)-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]heptanoic acid
- Englischer Name
- PROSTAGLANDIN A1
- Summenformel
- C20H32O4
- Molmasse
- 336.47
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
14152-28-4- PubChem CID
- 5281912
- DTXSID
DTXSID601347314- ChEMBL
CHEMBL1084644- ChEBI
CHEBI:15545- UNII
- VYR271N44P
- EC Number
- 682-017-9
- Nikkaji
- J15.628K
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 4,4
- Polarare Oberfläche (TPSA)
- 74,6 Ų
- H-Brücken-Donoren
- 2
- H-Brücken-Akzeptoren
- 4
- Frei drehbare Bindungen
- 13
- Schwere Atome
- 24
- Formalladung
- 0
- Komplexität
- 439
Experimentelle und physikochemische Eigenschaften
Physikochemische Eigenschaften
- Schmelzpunkt
- 43 °C · 43°C
- Siedepunkt
- 392.93 °C · 392.93°C (rough estimate)
- Dichte
- 1.0192 · 1.0192 (rough estimate)
- Brechungsindex
- 1.4434 · 1.4434 (estimate)
- storage temp.
- -20 °C · -20°C
- Löslichkeit
- 10 mg/mL, · acetone: 10 mg/mL, clear
- Aggregatzustand
- White solid.
- pka
- 4.77 · 4.77±0.10(Predicted)
- Farbe
- Off-white
- Biologische Quelle
- synthetic
- BRN
- 2003401 · 2003401
- Stabilität
- 1 year · Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 1 month.
- InChI
- 1S/C20H32O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h12-18,21H,2-11H2,1H3,(H,23,24)/b14-12+/t16-,17-,18+/m0/s1
- InChIKey
- BGKHCLZFGPIKKU-LDDQNKHRSA-N
- SMILES
- O=C1[C@H](CCCCCCC(O)=O)[C@@H](/C=C/[C@H](CCCCC)O)C=C1
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Danger
H301 (50%): Toxic if swallowed [Danger Acute toxicity, oral]
P203, P264, P270, P280, P301+P316, P301+P317, P318, P321, P330, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Gefahrenhinweise
Sicherheitsdaten
- F
- 8-10
- wgk
- 3
- hs_code
- 2937500000
- RTECS-Nr.
- GY5977900
- safety_code
- 22-24/25
- Speicherklasse
- 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
- Hazard Classifications
- Acute Tox. 4 OralRepr. 1B
Chemie und Industrie
Pharmakologische Informationen
MeSH Pharmacological Classification
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
Anwendungen
BeschreibungProstaglandin A1 (PGA1) was first isolated as a dehydration product of the PGE1 compounds found in human semen. It has been shown to cause renal vasodilation, increased urine sodium excretion, and lowered arterial pressure in hypertensive patients. It also has growth-inhibitory activity on tumor cells; the IC50 value for the inhibition of human ovarian cancer is 7.5 μM.
VerwendenProstaglandin A1 has been shown to inhibit human immunodeficiency virus type 1 (HIV-1) replication in various cell types. In addition, as a precursor to the anti-inflammatory prostaglandins, it activates pro-inflammatory PGD2 receptor CRTH2 initiating the anti-inflammatory response.
Anbieter35 Anbieter
Zugehörige Reaktionen
Verknüpfte Notizen
Wird geladen…